Ratio of Active Matrix Metalloproteinases and Proenzymes during Growth and Metastasizing of Mouse Lewis Lung Adenocarcinoma

Verfasser / Beitragende:
[Ya. Kisarova, V. Kaledin, L. Bogdanova, T. Korolenko]
Ort, Verlag, Jahr:
2015
Enthalten in:
Bulletin of Experimental Biology and Medicine, 159/4(2015-08-01), 486-489
Format:
Artikel (online)
ID: 60553571X
LEADER caa a22 4500
001 60553571X
003 CHVBK
005 20210128100849.0
007 cr unu---uuuuu
008 210128e20150801xx s 000 0 eng
024 7 0 |a 10.1007/s10517-015-2999-1  |2 doi 
035 |a (NATIONALLICENCE)springer-10.1007/s10517-015-2999-1 
245 0 0 |a Ratio of Active Matrix Metalloproteinases and Proenzymes during Growth and Metastasizing of Mouse Lewis Lung Adenocarcinoma  |h [Elektronische Daten]  |c [Ya. Kisarova, V. Kaledin, L. Bogdanova, T. Korolenko] 
520 3 |a Ratio between proMMP and active MMP was studied in the dynamics of growth of the Lewis lung adenocarcinoma with lung metastasis. It was shown that tumor growth is associated with an increase in the content of proMMP (day 20; terminal stage), but the level of active MMP in tumor tissue did not signifi cantly change. The development of lung metastasis was accompanied by accumulation of active MMP (days 7, 15, and 20) and a decrease in the content of pro-MMP (days 7, and 20) in comparison with the control. In the spleen of these mice (metastasis-free organ), an increase in the levels of proMMP (day 20) and especially active MMP (days 7, 15, and 20) were found. The results suggest that tumor development shifts the proportion between active MMP and proenzymes in the tumor, lungs with metastasis, and spleen without metastasis. 
540 |a Springer Science+Business Media New York, 2015 
690 7 |a Lewis lung adenocarcinoma  |2 nationallicence 
690 7 |a lungs with metastasis  |2 nationallicence 
690 7 |a spleen  |2 nationallicence 
690 7 |a matrix metalloproteinases  |2 nationallicence 
690 7 |a proenzymes of matrix metalloproteinases  |2 nationallicence 
700 1 |a Kisarova  |D Ya  |u Research Institute of Physiology and Fundamental Medicine, Novosibirsk, Russia  |4 aut 
700 1 |a Kaledin  |D V.  |u Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Science, Moscow, Russia  |4 aut 
700 1 |a Bogdanova  |D L.  |u Institute of Molecular Pathology and Pathomorphology, Vienna, Austria  |4 aut 
700 1 |a Korolenko  |D T.  |u Research Institute of Physiology and Fundamental Medicine, Novosibirsk, Russia  |4 aut 
773 0 |t Bulletin of Experimental Biology and Medicine  |d Springer US; http://www.springer-ny.com  |g 159/4(2015-08-01), 486-489  |x 0007-4888  |q 159:4<486  |1 2015  |2 159  |o 10517 
856 4 0 |u https://doi.org/10.1007/s10517-015-2999-1  |q text/html  |z Onlinezugriff via DOI 
898 |a BK010053  |b XK010053  |c XK010000 
900 7 |a Metadata rights reserved  |b Springer special CC-BY-NC licence  |2 nationallicence 
908 |D 1  |a research-article  |2 jats 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-springer 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1007/s10517-015-2999-1  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Kisarova  |D Ya  |u Research Institute of Physiology and Fundamental Medicine, Novosibirsk, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Kaledin  |D V.  |u Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Science, Moscow, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Bogdanova  |D L.  |u Institute of Molecular Pathology and Pathomorphology, Vienna, Austria  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Korolenko  |D T.  |u Research Institute of Physiology and Fundamental Medicine, Novosibirsk, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t Bulletin of Experimental Biology and Medicine  |d Springer US; http://www.springer-ny.com  |g 159/4(2015-08-01), 486-489  |x 0007-4888  |q 159:4<486  |1 2015  |2 159  |o 10517